Medicare Part D

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation
AMCP Caragon

Implications for Managed Care Pharmacy from the 2021 and 2022 Medicare Advantage and Part D Proposed Rule

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.
Generic Drugs, Government/Legal Affairs, Medicare Part D, Medication Therapy Management (MTM), Quality Care, Star Ratings, Legislation & Regulation

AMCP submits comments to the Centers for Medicare and Medicaid Services (CMS) in response to its proposed rule, “Medicare Program; Secure Electronic Prior Authorization for Medicare Part D.”

The Academy of Managed Care Pharmacy (AMCP) thanks the Centers for Medicare and Medicaid Services (CMS) for the opportunity to provide comments in response to its proposed rule, “Medicare Program; Secure Electronic Prior Authorization for Medicare Part D [CMS-4819-P]” published in the Federal Register on June 19, 2019.
Medicare Part D